Fujifilm Life Sciences Corporate Venture Capital

Fujifilm is involved in a wide range of business in the three fields of Healthcare, Materials and Imaging through leveraging the expertise they have cultivated in photographic film.

As a total healthcare company, they develop a wide range of businesses in the three areas of "Prevention", "Diagnosis", and "Treatment". Fujifilm is contributing to the health of people around the world by responding to unmet medical needs, early detection of diseases, and support for the development and manufacture of innovative vaccines and pharmaceuticals.

In the Materials field, they are working on environmental issues such as promoting resource recycling and responding to climate change, by improving industrial efficiency and promoting ICT in society.

In the field of Imaging, they give form to a wide range of memories and events through film and photographs, and contribute to enrich emotional lives and stronger human connections.

The fund raises to $60M and it will be used to target partnerships with promising early-stage biotechnology companies to enhance Fujifilm's life sciences portfolio. It will be managed by the Life Sciences Corporate Venture Capital (LS-CVC), a new group established within Fujifilm's Life Sciences Strategy Headquarters in Tokyo.

The fund's mission is to accelerate business growth within the life sciences industry, specifically through contract biopharmaceutical development and manufacturing, drug discovery research markets and industrial cell culture media.

Applicants willing to get in touch with Fujifilm can contact them through this link.

 Portfolio: Synapse, REiLI, Synapse 3D, AI Lab.

Last update: April 18, 2022